16 research outputs found
Effects of thiostrepton alone or in combination with selumetinib on triple-negative breast cancer metastasis
Objective FoxM1 transcription factor contributes to tumor metastasis and poor prognosis in many cancers including triple-negative breast cancer (TNBC). In this study, we examined the effects of FoxM1 inhibitor Thiostrepton (THIO) alone or in combination with MEK inhibitor Selumetinib (SEL) on metastatic parameters in vitro and in vivo. Methods Cell viability was determined by MTT assay. Immunoblotting and immunohistochemistry was used to assess metastasis-related protein expressions in 4T1 cells and its allograft tumor model in BALB/c mice. In vivo uPA activity was determined by enzymatic methods. Results Both inhibitors were effective on the expressions of FoxM1, ERK, p-ERK, Twist, E-cadherin, and Vimentin alone or in combination in vitro. THIO significantly decreased 4T1 cell migration and changed the cell morphology from mesenchymal-like to epithelial-like structure. THIO was more effective than in combination with SEL in terms of metastatic protein expressions in vivo. THIO alone significantly inhibited mean tumor growth, decreased lung metastasis rate and tumor foci, however, no significant changes in these parameters were observed in the combined group. Immunohistochemically, FoxM1 expression intensity was decreased with THIO and its combination with SEL in the tumors. Conclusions This study suggests that inhibiting FoxM1 as a single target is more effective than combined treatment with MEK in theTNBC allograft model. The therapeutic efficacy of THIO should be investigated with further studies on appropriate drug delivery systems.Scientific and Technological Research Council of Turkey, (TUBITAK) [1002116S162]; Teaching Staff Training Program of TurkeyThis work was supported by the Scientific and Technological Research Council of Turkey, (TUBITAK) under Grant (number 1002116S162) and Teaching Staff Training Program of Turkey
Efficacy of a novel LyP-1-containing self-microemulsifying drug delivery system (SMEDDS) for active targeting to breast cancer
An ideal cancer therapy targets the tumor cells selectively without
damaging healthy tissues. Even though the tumor-specific markers are
limited, these molecules can be used for the delivery of anti-cancer
drugs as an active targeting strategy. Since the lymphatic system plays
a critical role in the dissemination of cancer cells, the drugs directed
through lymphatics can feasibly reach to the sites of metastasis. LyP-1
is a peptide that binds to the p32 receptor which is highly expressed
not only on the lymphatic endothelium but also on the malignant cells;
thus, making this peptide ligand a preferable candidate to mediate
active targeting of lymphatics and cancer cells. In this study,
different formulations of LyP-1 containing lipid-based nanophannaceutics
so-called self-microemulsifying drug delivery systems (SMEDDS) were
developed and tested for their efficacy in targeting breast cancer.
Following the selection of non-toxic formulation, doxorubicin
hydrochloride and LyP-1 were co-administered in the SMEDDS, which
resulted in a significant increase in in vitro cytotoxicity in
p32-expressing breast cancer cells, 4T1 and MDA-MB-231. Accordingly, the
uptake of LyP-1 in the SMEDDS by the cancer cells was demonstrated. The
expression of p32 was detected in the 4T1 tumor tissues which were
efficiently targeted with LyP-1 in the SMEDDS. When doxorubicin was
co-administrated with LyP-1 in SMEDDS via intraperitonial
administration, tumor growth and metastasis were significantly reduced.
In conclusion, a novel and efficacious SMEDDS formulation containing
LyP-1 with a droplet size less than 100 nm was developed for the
lymphatic targeting of breast cancer
Primary Tumor Cells Obtained from Mnu-Induced Mammary Carcinomas Show Immune Heterogeneity Which Can Be Modulated by Low-Efficiency Transfection of Cd40L Gene
The presence of CD40 on carcinoma cells is an important factor for the generation of tumor-specific responses induced by CD40 ligation. In an N-methyl-N-nitrosourea (MNU)-induced autochthonous mammary tumor model, we analyzed the immune features of primary tumor cells. Here, CD40 was frequently detected on the primary tumor cultures and selectively expressed on the malignant mammary tissue in vivo. On the other hand, every mammary tumor cell culture had a heterogeneous and reduced expression of proinflammatory TNF alpha, IL-1 beta, IL-6 and CXCL1 cytokines compared to normal mammary epithelial cells. Low-efficiency transfection of CD40 ligand (CD40L) gene enhanced the expression of proinflammatory cytokines in the tumor cells, and strengthened allogeneic immune reactions and costimulatory activity which may help overwhelming suppressive features of the tumor.WoSScopu
Pazopanib-Induced Hepatotoxicity in an Experimental Rat Model
WOS: 000425214300007PubMed: 29393107Pazopanib is an effective treatment for advanced renal cell carcinoma and soft tissue sarcoma. Besides classical adverse events of this drug class, hepatotoxicity has been described as a frequent side effect. the aim of the present study was to evaluate the effect of pazopanib on the liver in an experimental rat model. Sixteen Wistar albino rats were divided into 3 groups: experimental toxicity was induced with pazopanib (10 mg/kg) administered for 28 days (group 2) or 56 days (group 3) orally by gavage. Group 1 (control group) received only distilled water. Rats in groups 2 and 3 were sacrificed after the collection of blood and tissue samples on the 28th and 56th days, respectively. We found significant differences in bilirubin, alkaline phosphatase, lactate dehy- drogenase, glucose, triglyceride, very-low-density lipoprotein, and iron values (p 0.050). All rats in the control group had normal histological features; however, none of the rats in groups 2 and 3 showed normal histology. in group 2, we observed mild sinusoidal dilatation, congestion, enlarged Kupffer cells, accumulation of yellow-brown-black pigment in the Kupffer cells and the accumulation of hemosiderin with Prussian blue reaction in the hepatocytes. in group 3, the findings mentioned above were more prominent, and besides these findings focal acinar transformation and macrovesicular steatosis were also observed. in group 3, mild inflammation within the portal areas was observed consisting of lymphocytes, neutrophils, and eosinophils. This study is the first that reports the biochemical and histopathological evaluation of pazopanib-related hepatic toxicity. (C) 2018 S. Karger AG, Base
The Relationship Between Plexin C1 Overexpression and Survival in Hepatocellular Carcinoma: a Turkish Oncology Group (TOG) Study
kose, fatih/0000-0002-0156-5973WOS:000625053000002PubMed: 33656690Purpose Plexin C1 is a transmembrane receptor and plexin C1 overexpression might have role in carcinogenesis. Hepatocellular carcinoma (HCC) has poor prognosis because of its aggressive behavior and limited treatment options, especially in advanced stage. We recently documented that Plexin C1 was overexpressed in HCC. We aimed to evaluate the prognostic significance of Plexin C1 overexpression in HCC in the present study. Methods Plexin C1 overexpression was evaluated immunohistochemically on paraffin-embedded blocks of the HCC patients. Plexin C1 immunohistochemical staining was scored. Plexin C1 overexpression staining intensity and prevalence were used for plexin scale staining evaluation and plexin scores were estimated according this staining scale. Plexin C1 score and its association with survival and clinicopathological features was assessed. Results Sixty-seven HCC patients with adequate tissue for pathological evaluation were included. Median age was 63 years with male predominance (male to female ratio was 4.75 (n 57/12). Well-differentiated HCC (53.7%) patients had higher plexin C1 overexpression (p < 0.05). Median OS was 22.1 months. Patients with lower plexin C1 score (< 12) had shorter OS (17.5 vs 30.1 months, p = 0.036). Neutrophil count, GGT, and PNR (platelet/neutrophil ratio) had prognostic significance (p = 0.047, p = 0.018, and p = 0.045). Conclusion Plexin C1 overexpression is inversely correlated with grade in HCC. The patients with lower rate of Plexin C1 overexpression have worse survival outcome. It might be a prognostic factor in HCC
Is it possible that the pathogenesis of osteoarthritis could start with subchondral trabecular bone loss like osteoporosis?
Objectives: This study aims to investigate the role of subchondral
trabecular bone thickness in the mechanism of knee osteoarthritis and
the correlation of osteoarthritis and osteoporosis pathogenesis.
Patients and methods: The study included 62 patients (9 males, 53
females, mean age 66.7 years; range, 50 to 84 years) with osteoarthritk
All radiographs were evaluated according to Kellgren and Lawrence
classification. The bone mineral density of the patients was measured
and bone samples were collected from all patients included in the study
during the surgical procedure and investigated pathologically.
Results: Osteoarthritis grade and trabecular bone thickness were
correlated with each other. Trabecular thickness rate was higher in
patients with severe osteoarthritis, whereas trabecular thickness rate
was statistically significantly lower than the mean in patients with
mild osteoarthritis (p=0.045).
Conclusion: Trabecular thickness rate was significantly lower in the
mild grade of osteoarthritis compared to the severe grade. As the level
of osteoarthritis increased, the number of patients with osteoporosis
decreased
Dual actions of the antioxidant chlorophyllin, a glutathione transferase P1-1 inhibitor, in tumorigenesis and tumor progression
Glutathione (GSH) and enzymes related to this antioxidant molecule are often overexpressed in tumor cells and may contribute to drug resistance. Blockade of glutathione transferases (GSTs) has been proposed to potentiate the efficacy of chemotherapeutic drugs in cancer. The aim of this study was to evaluate the effect of chlorophyllin that has antioxidant properties, and also interferes with the activity of GST P1-1, on breast cancers in vitro and in vivo. The in vivo studies were conducted using an N-methyl-N-nitrosourea (MNU)-induced chemical carcinogenesis model in laboratory rats. DNA damage, GST activity, and GSH levels were determined in liver and tumor tissues. Treatment with chlorophyllin increased the GSH levels in the liver and significantly decreased DNA damage in the blood, liver, and tumor tissues. Even though tumorigenesis was delayed in rats receiving chlorophyllin before MNU injections, once the tumors emerged, the progression of tumor appeared to be faster than in the animals that received the carcinogen only. Out of nine breast cell lines, GST P1-1 expression was detected in MCF-12A, MDA-MB-231, and HCC38. Concomitant incubation with chlorophyllin and docetaxel did not significantly affect cell proliferation and viability. Chlorophyllin displayed genoprotective effects that initially delayed tumorigenesis. However, once the tumors were established, it may act as a promoter that facilitates tumor growth, potentially by a mechanism independent of cell proliferation and viability. Our results underline the pros and cons of antioxidant treatment in cancer, even if it has a capacity to inhibit GST P1-1
Dual actions of the antioxidant chlorophyllin, a glutathione transferase P1‐1 inhibitor, in tumorigenesis and tumor progression
Glutathione (GSH) and enzymes related to this antioxidant molecule are often overexpressed in tumor cells and may contribute to drug resistance. Blockade of glutathione transferases (GSTs) has been proposed to potentiate the efficacy of chemotherapeutic drugs in cancer. The aim of this study was to evaluate the effect of chlorophyllin that has antioxidant properties, and also interferes with the activity of GST P1-1, on breast cancers in vitro and in vivo. The in vivo studies were conducted using an N-methyl-N-nitrosourea (MNU)-induced chemical carcinogenesis model in laboratory rats. DNA damage, GST activity, and GSH levels were determined in liver and tumor tissues. Treatment with chlorophyllin increased the GSH levels in the liver and significantly decreased DNA damage in the blood, liver, and tumor tissues. Even though tumorigenesis was delayed in rats receiving chlorophyllin before MNU injections, once the tumors emerged, the progression of tumor appeared to be faster than in the animals that received the carcinogen only. Out of nine breast cell lines, GST P1-1 expression was detected in MCF-12A, MDA-MB-231, and HCC38. Concomitant incubation with chlorophyllin and docetaxel did not significantly affect cell proliferation and viability. Chlorophyllin displayed genoprotective effects that initially delayed tumorigenesis. However, once the tumors were established, it may act as a promoter that facilitates tumor growth, potentially by a mechanism independent of cell proliferation and viability. Our results underline the pros and cons of antioxidant treatment in cancer, even if it has a capacity to inhibit GST P1-1